Steward Partners Investment Advisory’s Progenics Pharmaceuticals Inc PGNX Stock Holding History
Bought
Maintained
Sold
Other funds holding PGNX
Steward Partners Investment Advisory's PGNX Position: Q2 2020 in Review
Steward Partners Investment Advisory sold out of Progenics Pharmaceuticals Inc (PGNX) in Q2 2020, closing a stake of 1,500 shares — an estimated $5K sold.
Steward Partners Investment Advisory first reported a position in PGNX in Q2 2018 and held it in 6 quarters. The position peaked at $12K in Q2 2018. 3 funds tracked by Wall St. Rank hold PGNX as of Q2 2020.
- Steward Partners Investment Advisory reported no remaining Progenics Pharmaceuticals Inc position as of Q2 2020 after selling out during the quarter.
- Steward Partners Investment Advisory sold 1,500 Progenics Pharmaceuticals Inc shares in Q2 2020, an estimated $5K.
- Steward Partners Investment Advisory first reported a position in Progenics Pharmaceuticals Inc in Q2 2018 and held it in 6 quarters.
- Steward Partners Investment Advisory's Progenics Pharmaceuticals Inc position peaked at $12K in Q2 2018.
- 3 funds tracked by Wall St. Rank held Progenics Pharmaceuticals Inc as of Q2 2020.
Based on Steward Partners Investment Advisory's 13F filing for Q2 2020, filed 6 Aug 2020.